Jungbluth et al. [14] observed that MAGE-C1/CT7 gene expression is related to disease progression in myeloma due to its high expression in samples of MM stage III, compared to individuals with MGUS. This evidence concerns the gene MAGEC1 and plasma cell myeloma.